Compression Therapy Research: Strong Evidence for Specific Conditions

The Evidence Landscape

Compression therapy enjoys one of the stronger evidence bases in circulatory medicine, particularly for venous disorders. The research spans several decades and includes numerous randomised controlled trials, systematic reviews, and real-world observational studies.

Cochrane reviews — the gold standard for evidence synthesis — have examined compression therapy for multiple conditions. The most robust evidence exists for venous leg ulcers, where compression is considered first-line treatment. NICE guidelines recommend compression bandaging for all patients with venous leg ulcers, unless arterial disease contraindicates it.

For lymphoedema management, the evidence base includes both RCTs and extensive clinical experience, though fewer large-scale trials exist compared to venous conditions. Athletic recovery represents the newest area of research, with studies emerging over the past two decades but smaller sample sizes overall.

Key Research Findings

The strongest evidence comes from venous disease research. A 2012 Cochrane review of compression for venous leg ulcers analysed data from over 2,000 patients across multiple trials. Results consistently showed faster healing times with compression compared to no compression, with number needed to treat values around 5-6 for additional healing at 24 weeks.

For chronic venous insufficiency, systematic reviews demonstrate that compression stockings reduce symptoms like pain, swelling, and heaviness. A large RCT published in the New England Journal of Medicine followed 153 patients with venous ulcers for two years, finding that compression stockings reduced recurrence rates by approximately 60%.

Lymphoedema research shows that compression garments maintain volume reduction achieved through manual lymphatic drainage. Studies typically involve 50-200 participants and demonstrate sustained benefits when compression is used consistently. The evidence here is less about dramatic improvement and more about preventing deterioration.

Athletic recovery studies present mixed but promising results. Research on delayed onset muscle soreness shows modest benefits, with effect sizes typically in the small to moderate range. A 2017 meta-analysis of compression garments for exercise recovery included 32 studies with over 800 participants, suggesting small improvements in perceived muscle soreness and possibly strength recovery.

Research Limitations and Gaps

Several methodological challenges limit the compression therapy evidence base. Blinding participants to compression interventions proves nearly impossible, potentially introducing bias in subjective outcome measures. Control group selection varies widely — some studies compare compression to no treatment, others to placebo garments with minimal pressure.

Dosage standardisation remains problematic. Studies use different pressure levels, compression materials, and wearing schedules, making direct comparisons difficult. The optimal pressure gradient for specific conditions isn't definitively established, with recommendations often based on clinical consensus rather than head-to-head trials.

Publication bias likely affects the athletic recovery literature, where positive results appear more frequently in journals than negative ones. Many studies in this area also have short follow-up periods, leaving long-term effects unknown.

Patient selection criteria vary significantly across trials. Some include participants with mild symptoms whilst others focus on severe cases, limiting generalisability of findings.

What the Evidence Supports

The research clearly supports compression therapy for specific medical conditions. For venous leg ulcers, the evidence is unequivocal: compression accelerates healing when combined with appropriate wound care. Chronic venous insufficiency symptoms improve with graduated compression stockings, particularly when worn consistently.

Lymphoedema management benefits from compression therapy, though the evidence emphasises maintenance rather than initial volume reduction. Complex decongestive therapy — including compression — represents standard care in most clinical guidelines.

For athletic recovery, the evidence suggests modest benefits for perceived muscle soreness and potentially for strength recovery, but these effects are generally small. The research doesn't support compression as a standalone recovery strategy but rather as one component of comprehensive recovery protocols.

What remains uncertain includes optimal pressure levels for different conditions, ideal wearing schedules, and long-term effects of compression use. The athletic recovery field particularly needs larger, longer-term studies with objective outcome measures rather than relying primarily on subjective pain scores.

Future Research Directions

Priority research areas include dose-finding studies to establish optimal pressure levels for specific conditions. Current recommendations often rely on clinical experience rather than systematic comparison of different compression levels.

Long-term safety and efficacy studies are needed, particularly for athletic populations who may use compression frequently over many years. Most current studies follow participants for weeks or months rather than years.

Personalised compression approaches warrant investigation. Research into patient characteristics that predict compression therapy response could improve treatment targeting and reduce unnecessary interventions.

The athletic recovery field needs mechanistic studies to understand how compression affects muscle physiology, inflammation, and recovery processes. Current research focuses heavily on outcomes without adequately explaining underlying mechanisms.

Health economics research could inform policy decisions about compression therapy provision, particularly for preventive uses in chronic venous disease. Cost-effectiveness data would support more widespread access to evidence-based compression interventions.